GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » Equity-to-Asset

Lobe Sciences (XCNQ:LOBE) Equity-to-Asset : -0.59 (As of Feb. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Lobe Sciences's Total Stockholders Equity for the quarter that ended in Feb. 2024 was C$-1.24 Mil. Lobe Sciences's Total Assets for the quarter that ended in Feb. 2024 was C$2.11 Mil.

The historical rank and industry rank for Lobe Sciences's Equity-to-Asset or its related term are showing as below:

XCNQ:LOBE' s Equity-to-Asset Range Over the Past 10 Years
Min: -35.4   Med: 0.89   Max: 1
Current: -0.59

During the past 13 years, the highest Equity to Asset Ratio of Lobe Sciences was 1.00. The lowest was -35.40. And the median was 0.89.

XCNQ:LOBE's Equity-to-Asset is ranked worse than
90.42% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs XCNQ:LOBE: -0.59

Lobe Sciences Equity-to-Asset Historical Data

The historical data trend for Lobe Sciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences Equity-to-Asset Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.92 0.93 0.93 0.26 -0.07

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 -0.70 -0.07 -0.31 -0.59

Competitive Comparison of Lobe Sciences's Equity-to-Asset

For the Biotechnology subindustry, Lobe Sciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's Equity-to-Asset falls into.



Lobe Sciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Lobe Sciences's Equity to Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Equity to Asset (A: Aug. 2023 )=Total Stockholders Equity/Total Assets
=-0.16/2.299
=-0.07

Lobe Sciences's Equity to Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

Equity to Asset (Q: Feb. 2024 )=Total Stockholders Equity/Total Assets
=-1.235/2.109
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lobe Sciences  (XCNQ:LOBE) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Lobe Sciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (XCNQ:LOBE) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines